Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to detect adverse drug reactions for long-term use (particularly clinically significant adverse drug reactions) occurring in clinical settings, to examine factors likely to affect the safety and efficacy in the Japanese asthma patients who are treated with fluticasone propionate/salmeterol xinafoate.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Fluticasone-Salmeterol Drug Combination; Salmeterol Xinafoate

Criteria

Inclusion Criteria:

• Must use fluticasone and salmeterol for the first time

• Must use fluticasone and salmeterol for long-term

Exclusion Criteria:

• Patients with hypersensitivity to salmeterol and fluticasone

• Patients with infection which salmeterol and fluticasone is not effective

• Patients with deep mycosis